Literature DB >> 16026084

[Immunological and serological laboratory tests: transthyretin].

Yukio Ando1.   

Abstract

Transthyretin (TTR) is a beta-sheet rich protein whose plasma half life is 1.9 days. It behaves as a tetramer and binds to retinol binding protein (RBP) and thyroxin in plasma. Since TTR is a tryptophan-rich-protein, the protein is used as a useful marker protein for nutrition supporting team (NST). However, TTR is also an anti-acute phase protein, and the concentration is influenced by various conditions, such as inflammation and infection, Mutated forms of TTR are the precursor protein of familial amyloidotic polyneuropathy (FAP). Since plasma TTR is predominantly synthesized by the liver, liver transplantation has been performed as an effective therapy for FAP. Recent research revealed that TTR plays important roles in various central nervous system disorders, such as Alzheimer disease, depression, and lead intoxication. To elucidate the pathogenesis of those disorders, an accurate measurement of TTR concentrations in plasma and cerebrospinal fluids is of vital importance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026084

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  2 in total

1.  Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Authors:  Hongtao Wang; James P Malone; Petra Erdmann Gilmore; Alan E Davis; John C Magee; R Reid Townsend; Robert O Heuckeroth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

2.  Changes of transthyretin and clusterin after androgen ablation therapy and correlation with prostate cancer malignancy.

Authors:  Daohu Wang; Hui Liang; Xiaopeng Mao; Wei Liu; Mingtao Li; Shaopeng Qiu
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.